Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia
Jorge J. Yunis(University of Minnesota), Richard D. Brunning(University of Minnesota), Robert E. Rydell(University of Minnesota), Mary Mayer(University of Minnesota), Martin M. Oken(Minneapolis Heart Institute Foundation), Mark A. Arnesen(University of Minnesota), Michael Lobell(University of Minnesota)
Cited by 233
Related Papers
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
|Blood|2009|4.4k
Diagnostic criteria and classification of mastocytosis: a consensus proposal
|Leukemia Research|2001|1.1k
Virus-associated hemophagocytic syndromeA benign histiocytic proliferation distinct from malignant histiocytosis
|Cancer|1979|1.1k
Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia.
|Journal of Clinical Oncology|1990|785